Search Results - "Kaul, Monika D"

  • Showing 1 - 2 results of 2
Refine Results
  1. 1
    The Timing, Trajectory, and Incidence of Immune-Related Adverse Events in NSCLC Treated With Atezolizumab

    The Timing, Trajectory, and Incidence of Immune-Related Adverse Events in NSCLC Treated With Atezolizumab by Smith, Katherine E R, Pritzl, Stephanie L, Yu, Wei, Bara, Ilze, Thanarajasingam, Gita, Kaul, Monika D, Williams, Kirstin A, Dueck, Amylou C, Mansfield, Aaron S

    Published in JTO clinical and research reports (01-12-2023)
    “…Immune-related adverse events (irAEs) due to immune checkpoint inhibitors can have complicated clinical courses. We comprehensively evaluated the timing,…”
    Get full text
    Journal Article
    Save to List
    Saved in:
  2. 2
    Association of Immune-Related Adverse Events With Efficacy of Atezolizumab in Patients With Non-Small Cell Lung Cancer: Pooled Analyses of the Phase 3 IMpower130, IMpower132, and IMpower150 Randomized Clinical Trials

    Association of Immune-Related Adverse Events With Efficacy of Atezolizumab in Patients With Non-Small Cell Lung Cancer: Pooled Analyses of the Phase 3 IMpower130, IMpower132, and IMpower150 Randomized Clinical Trials by Socinski, Mark A, Jotte, Robert M, Cappuzzo, Federico, Nishio, Makoto, Mok, Tony S K, Reck, Martin, Finley, Gene G, Kaul, Monika D, Yu, Wei, Paranthaman, Nindhana, Bara, Ilze, West, Howard J

    Published in JAMA oncology (01-04-2023)
    “…Immune-related adverse events (irAEs) arising from immune checkpoint inhibitor (ICI) cancer therapy may potentially predict improved outcomes. To evaluate the…”
    Get more information
    Journal Article
    Save to List
    Saved in:

Search Tools: